Comparision of Visual Outcomes and Patient Satisfaction Between Two Diffractive Trifocal Intraocular Lenses
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cataract Senile
- Sponsor
- Akdeniz University
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- The Quality of Vision score
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The purpose of the present study was to compare the clinical outcomes such as visual function, refraction errors and visual quality of patients undergoing cataract surgery with implantation of two different models of diffractive trifocal IOLs: RayOne Trifocal (Rayner IOL, Ltd.) and AcrySof IQ PanOptix (Alcon Laboratories, Inc.) IOL.
Detailed Description
Cataract is affecting over 95 million people worldwide and remains the leading cause of vision impairment and blindness. Cataract surgery is an effective method for restoring visual acuity (VA). With the advancement of cataract surgery technique and intraocular lenses (IOL) technologies, expectations of patients from cataract surgery have good vision at distance and near ranges without using spectacles. The standard IOLs design were monofocal, which offered only fixed focal distance. One of the main factors for dissatisfaction after monofocal pseudophakic eyes is lack of accommodation. Previous studies demonstrated that this problem can be resolved by using diffractive trifocal IOLs. Diffractive trifocal IOLs provide effective near, intermediate and distance visual restoration, and has been widely used in patients who want to achieve spectacle independence after surgery. However, some possible optical side effects of trifocal IOLs have been reported, including halos and other dysphotopsias, reduced contrast sensitivity (CS), glare disability, which can significantly affect visual quality and patient satisfaction. The purpose of the present study was to compare the clinical outcomes such as visual function, refraction errors and visual quality of patients undergoing cataract surgery with implantation of two different models of diffractive trifocal IOLs: RayOne Trifocal (Rayner IOL, Ltd.) and AcrySof IQ PanOptix (Alcon Laboratories, Inc.) IOL.
Investigators
Aslı Çetinkaya Yaprak
Principal Investigator
Akdeniz University
Eligibility Criteria
Inclusion Criteria
- •Patients underwent cataract surgery with trifocal intraocular lenses implantation in one or both eyes
Exclusion Criteria
- •Amblyopia
- •Axial length (AL) over 25 mm
- •Previous history of corneal or refractive surgery
- •Ocular comorbidity (corneal scars, keratoconus, and corneal endothelial dystrophy, chronic or recurrent uveitis, macular degeneration, diabetes mellitus with retinal changes, glaucoma or intraocular pressure equal or higher than 24 mmHg)
- •Patient inability to understand and/or fill in patient questionnaires
Outcomes
Primary Outcomes
The Quality of Vision score
Time Frame: 3 months
Glare, halos, starbursts, hazy/blurred/double vision, distortion, focusing difficulties, fluctuation, and depth perception